Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARB vs Diuretics in Hypertension Patients With High Cardiovascular Risks
NCT01011660Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2007
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan and amiloride in essential hypertension (4 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Composite of non-fatal stroke, non-fatal myocardial infarction and cardiovascular death. Status: unknown.
02
Drugs
telmisartanamiloride
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01011660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011660.